Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

PARKINSON’S DISEASE

Dysregulated miRNAs mark Parkinson’s disease progression

Nature Aging volume 1, pages 241–242 (2021)Cite this article

Subjects

Biomarkers for Parkinson’s disease are critical to our efforts to identify disease-modifying therapies. Kern et al. document potential microRNA (miRNA) biomarkers and trends in miRNA regulation that occur in a bimodal distribution with age.

This is a preview of subscription content, access via your institution

Access options

Fig. 1: Dysregulation of miRNAs in two distinct waves during progression of PD.

References

  1. Stocchi, F. & Olanow, C. W. Movement Disord. 28, 3–7 (2013).

    Article  CAS  Google Scholar 

  2. Kern, F. et al. Nat. Aging https://doi.org/10.1038/s43587-021-00042-6 (2021).

  3. Marek, K. et al. Ann. Clin. Transl. Neur. 5, 1460–1477 (2018).

    Article  CAS  Google Scholar 

  4. Rosenthal, L. S. et al. Movement Disord. 31, 915–923 (2016).

    Article  CAS  Google Scholar 

  5. Mohammadi, D. Lancet Neurol. 12, 739–740 (2013).

    Article  Google Scholar 

  6. Martins, M. et al. PLoS ONE 6, e25443 (2011).

    Article  CAS  Google Scholar 

  7. Caggiu, E. et al. eNeurologicalSci 13, 1–4 (2018).

    Article  Google Scholar 

  8. Chi, J. et al. Front. Aging Neurosci. 10, 178 (2018).

    Article  Google Scholar 

  9. Ravanidis, S. et al. Ann. Clin. Transl. Neur. 7, 1594–1607 (2020).

    Article  CAS  Google Scholar 

  10. Ferguson, L. W., Rajput, A. H. & Rajput, A. Can. J. Neurol. Sci. 43, 113–119 (2016).

    Article  Google Scholar 

  11. Mehanna, R. et al. Parkinsonism Relat. D. 20, 530–534 (2014).

    Article  Google Scholar 

  12. Goodsaid, F. M. & Mendrick, D. L. Sci. Transl. Med. 2, 47ps44 (2010).

    Article  Google Scholar 

  13. List of qualified biomarkers. U.S. Food and Drug Administration https://www.fda.gov/drugs/biomarker-qualification-program/list-qualified-biomarkers (2021).

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA

    Liana S. Rosenthal & Xiaobo Mao

  2. Institute for Cell Engineering, Johns Hopkins School of Medicine, Baltimore, MD, USA

    Jun Yang & Xiaobo Mao

Authors
  1. Liana S. Rosenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaobo Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Liana S. Rosenthal.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rosenthal, L.S., Yang, J. & Mao, X. Dysregulated miRNAs mark Parkinson’s disease progression. Nat Aging 1, 241–242 (2021). https://doi.org/10.1038/s43587-021-00046-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43587-021-00046-2

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research